+39 06 5782665
contact@donawa.com
Europe - UK - USA

Global News Preview

Clinical Project Management: Webinar on 22nd October 2026
Running a medical device or IVD clinical study involves dozens of activities across three phases: preparation, enrolment, and close-out. A team carries out the work, but someone has to know what must happen, when, and who is responsible. That is clinical project management, and it is the part of a study less experienced Study Sponsors...
October 12, 2026
FDA announces fees for FY 2027

The US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) has published the user fees applicable to submissions, etc for fiscal year 2027, running from 1 October 2026 to 30 September 2027. The new fees represent between a 10% and 20% increase over the 2026 fees. Further details are available from…

September 16, 2026
Donawa Lifescience launches Donawa InTeam flexible clinical staffing service

Donawa Lifescience has launched the Donawa InTeam flexible clinical staffing service to provide medical device and IVD companies fast access to qualified clinical professionals — Clinical Project Managers, Clinical Research Associates and Clinical Study Assistants — who join the client’s team on a fixed assignment, with none of the delays typically associated with recruitment. Through Donawa…

September 14, 2026
MDCG Position Paper published on Management of SSCP/SSP in EUDAMED

The EU Medical Device Coordination Group (MDCG) has published a new guidance document, MDCG 2026-4, titled ‘MDCG Position Paper: Management of SS(C)P in EUDAMED after mandatory use’. The document explains that “The summary of safety and clinical performance and the summary of safety and performance (SSCP and SSP respectively), are to be uploaded by the…

July 8, 2026
FDA drafts new rule on use of electronic instructions for use

The US Food and Drug Administration (FDA) has released draft wording for a new rule that would allow gretaer use of electronic instructions for use for many types of medical device. The proposed rule, if finalized, would clarify that the “adequate directions for use” requirement under section 502(f) of the Federal Food, Drug, and Cosmetic…

July 8, 2026
FDA publishes guidance Q&A on Clinical Support Software

The US Food and Drug Administration has recently published a Q&A document on the subject of Clinical Support Software, following release of full guidance on the topic in January 2026. The Q&A explains that “Clinical Decision Support (CDS) software are important tools in modern health care. While some CDS software has been excluded from the…

July 4, 2026